Device, product and service companies at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
57 device, product and service companies are at IDWeek 2026 — 76 presentations on the program and 25 with a booth in the exhibit hall. Most represented: Element Materials Technology (6 on the program), Biobyte Brasil (2 on the program), Healix (2 on the program). 35 of them have their own page in this guide. As of Oct 16, 2026.
Topic
Top represented
Showing 1–7 of 57 organizations
| Organization | IDWeek 2026 Attendance |
|---|---|
Testing and certification company whose Jones Microbiology Institute, formerly JMI Laboratories, runs antimicrobial surveillance and susceptibility testing. | Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol-Xeruborbactam and Comparator Agents against Enterobacterales, Including Molecularly Characterized Isolates Recovered Globally in 2024 Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol-Xeruborbactam and Comparator Agents against Global Acinetobacter baumannii-calcoaceticus species complex Isolates Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol-Xeruborbactam and Comparator Agents against Pseudomonas aeruginosa, Including Molecularly Characterized Isolates Recovered Globally in 2024 Poster Thu Oct 22 12:15pm–1:30pm Activity of Ceftazidime-Avibactam against Pseudomonas aeruginosa from Patients with Ventilator-Associated Pneumonia (VAP) from United States Medical Centers (2021-2025). Poster Thu Oct 22 12:15pm–1:30pm Activity of Fosfomycin against Enterobacterales Collected from US Medical Centers during 2020-2023 Poster Thu Oct 22 12:15pm–1:30pm Activity of manogepix against Aspergillus spp. isolates with CYP51 alterations Poster Thu Oct 22 12:15pm–1:30pm Activity of manogepix against mold isolates across geographic regions Poster Thu Oct 22 12:15pm–1:30pm Activity of manogepix against yeast and mold isolates from 2025 in the United States Poster Thu Oct 22 12:15pm–1:30pm Activity of rezafungin against Aspergillus spp. that are non-wild-type to azole antifungal agents Poster Thu Oct 22 12:15pm–1:30pm Antimicrobial Activity of Aztreonam-Avibactam against Enterobacterales Isolated from Patients with Ventilator-Associated Pneumonia (VAP) Poster Thu Oct 22 12:15pm–1:30pm Antimicrobial Susceptibility and Molecular Characterization of Carbapenem-Resistant Klebsiella pneumoniae from United States Medical Centers (2020-2025) Poster Thu Oct 22 12:15pm–1:30pm Antimicrobial Susceptibility of KPC-Producing Enterobacterales and Molecular Characterization of Ceftazidime-Avibactam-Resistant Strains from United States Medical Centers (2018-2025). Poster Thu Oct 22 12:15pm–1:30pm Aztreonam-Avibactam Activity against Carbapenem-Resistant Enterobacterales from United States Medical Centers Stratified By year and Resistance Mechanism (2021-2025). Poster Thu Oct 22 12:15pm–1:30pm Aztreonam-Avibactam Activity against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in United States Medical Centers (2023–2025) Poster Thu Oct 22 12:15pm–1:30pm Aztreonam-avibactam activity against Enterobacterales from United States medical centers: Summary of 5 years of surveillance prior to approval for clinical use (2020-2024) Poster Thu Oct 22 12:15pm–1:30pm In vitro Activity of Cefiderocol (FDC) Against a Collection of Infrequently Isolated Gram-Negative Bacterial Isolates from the SENTRY Antimicrobial Surveillance Program Poster Thu Oct 22 12:15pm–1:30pm In vitro Activity of Ceftobiprole and Comparator Agents Against Contemporary US Clinical Isolates Collected in 2025 Following FDA Approval Poster Thu Oct 22 12:15pm–1:30pm Reproducibility of Cefiderocol-Xeruborbactam MIC Determinations in Cation Adjusted Mueller Hinton Broth and Iron Depleted CAMHB using Two Reading Endpoints Talk Fri Oct 23 12:25pm–12:30pm Aztreonam-Avibactam Activity against Carbapenem-Resistant Enterobacterales from United States Medical Centers Stratified By year and Resistance Mechanism (2021-2025). Antimicrobials, resistance and stewardship Talk Fri Oct 23 4:15pm–4:30pm Activity of manogepix against Candida auris isolates from the United States Antimicrobials, resistance and stewardship Poster Sat Oct 24 12:15pm–1:30pm Activity of Omadacycline and Comparators Against Common Microbial Contaminants: Cronobacter sakazakii, Pluralibacter gergoviae, and Burkholderia cepacia species complex isolates Poster Sat Oct 24 12:15pm–1:30pm In Vitro Activity of Omadacycline against 7,200 Bacterial Clinical Isolates Representing Multiple Infection Types from the United States (2024-2025) |
Brazilian company building software for automated surveillance of healthcare-associated infections. | Poster Thu Oct 22 12:15pm–1:30pm AI-Driven Automated Surveillance of Healthcare-Associated Infections Using Ensemble Machine Learning and CDC/NHSN Definitions Poster Thu Oct 22 12:15pm–1:30pm Automated Post-Discharge Surveillance for Surgical Site Infections via WhatsApp: Development and Validation of the SACIH System and Prediction Model Poster Thu Oct 22 12:15pm–1:30pm More is not Better: Prolonged Antimicrobial Prophylaxis does not Reduce Surgical Site Infection after Sacral and Sacropelvic Resections - Implications for Antimicrobial Stewardship Poster Thu Oct 22 12:15pm–1:30pm Treatment Failure in Orthopedic Implant–Associated Infections: MRSA and Prior Antimicrobial Exposure as Key Predictors |
Healix Sugar Land, TX | |
Runs a network of 300+ outpatient infusion centers and an accredited pharmacy that supplies injectable and infused medicines. | Booth Exhibiting at Booth 1243 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Poster Thu Oct 22 12:15pm–1:30pm Five-Year Real-World Trends in Outpatient Anti-Infective Therapy Across U.S. Physician Office Infusion Centers Session Fri Oct 23 12:15pm–12:45pm Rapid-Fire Poster Session: Old Foes, New Strategies Antimicrobials, resistance and stewardship Poster Sat Oct 24 12:15pm–1:30pm Infection Rate Reduction in Primary Immunodeficiency Patients Following Initiation of High-Titer Immunoglobulin: A Real-World Analysis |
Epividian Raleigh, NC | |
Clinical data company combining research, technology and clinical reporting for practices, researchers and public health agencies. | Poster Fri Oct 23 12:15pm–1:30pm Virologic Outcomes of Individuals Prescribed Dolutegravir/Lamivudine After an Oral Antiretroviral Therapy Treatment Interruption: Findings from the OPERA Cohort Poster Sat Oct 24 12:15pm–1:30pm Recalling Individuals at Higher Risk of HCV Acquisition for Screening Using a Clinical Decision Support System: Encouraging Findings from the OPERA Cohort |
Poster Thu Oct 22 12:15pm–1:30pm Budget Impact of MALDI-TOF–Guided Blood Culture Identification on Antibiotic De-escalation and Hospital Costs in Indian Tertiary Hospitals Poster Fri Oct 23 12:15pm–1:30pm State-Level Economic Burden and Preventable Costs of HIV-Associated Opportunistic Infections in India: Budget Impact Analysis | |
PRIME Education Fort Lauderdale, FL | |
Medical education company producing accredited continuing education for clinicians and health systems. | Poster Fri Oct 23 12:15pm–1:30pm Global Perspectives on Holistic Care: Amplifying Voices of Women and Gender-Diverse Persons Living With HIV to Identify Areas for Improvement Alongside Healthcare Providers (HCPs) Poster Fri Oct 23 12:15pm–1:30pm Integrating HIV Prevention into Psychiatric Care: An Educational Initiative for Improving PrEP Implementation Poster Sat Oct 24 12:15pm–1:30pm Aligning Inpatient COVID-19 Management With Regional Guidelines: A Global Initiative With Hospital Healthcare Providers (HCPs) Poster Sat Oct 24 12:15pm–1:30pm Building Vaccine Confidence Across the Lifespan Through Regionally Tethered Education for Community Members (CMs) and Healthcare Professionals (HCPs) Poster Sat Oct 24 12:15pm–1:30pm Community-Based UTI Education Improves Knowledge and Highlights Disparities in Socially Vulnerable Populations Poster Sat Oct 24 12:15pm–1:30pm Improving Infant RSV Prevention Through Tailored Education Across the Perinatal Care Continuum Poster Sat Oct 24 12:15pm–1:30pm Real-World Perspectives on RSV Vaccination: Identifying Motivators, Barriers, and Perceived Risk Among Racial and Ethnic Minority Older Adults |
Medscape Education New York, NY | |
Medscape's continuing education arm, offering free online accredited courses for physicians and other clinicians. | Poster Thu Oct 22 12:15pm–1:30pm Online Continuing Medical Education Enhances Clinical Understanding and Confidence in Metagenomic Next-Generation Sequencing Tests for Infectious Diseases Poster Sat Oct 24 12:15pm–1:30pm Online Continuing Medical Education Improves Clinical Readiness with Recommending Respiratory Syncytial Virus Vaccines Poster Sat Oct 24 12:15pm–1:30pm Online Continuing Medical Education Improves Outpatient COVID-19 Management and Multidisciplinary Clinical Practice in Adults at Higher Risk for Severe-Disease Related Complications Poster Sat Oct 24 12:15pm–1:30pm Online Continuing Medical Education and Tethered Patient Education Improves Understanding and Communication Around Influenza Immunization |
Instantly find 20 buyers from device, product and service companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse IDWeek 2026 by
Organization type
Topic
- Antimicrobials, resistance and stewardship 420
- Vaccines 122
- Diagnostics and diagnostic stewardship 247
- HIV, sexually transmitted infections and viral hepatitis 256
- Infection prevention and healthcare epidemiology 292
- Transplant and immunocompromised hosts 173
- Respiratory infections and COVID-19 163
- Global and public health 211
Exhibit hall
Everyone
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction